Search results

International neutron scattering award for retired head of former Bragg Institute, Prof Robert Robinson

Neutron scattering instruments used by Japanese researchers.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Professor Vanessa Peterson, Senior Principal Research and Neutron Scattering Instrument Scientist and Leader of the Energy Materials Research project, has been awarded the Bob Cheary Award or Excellence in Diffraction Analysis by the Australian X-ray Analytical Association. She is the first female to be chosen for the award.

Doping with transition metals produced stability in bismuth oxide.

Doping with transition metals produced stability in bismuth oxide.

The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

Data analysis on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.